DHS Hungary
Get in touch
DHS Hungary
Get in touch

Watchman

Close

Watchman FLX at Military Hospital

Boston Scientific, LAAC, WatchmanMay 19, 2026231Views0Likes0Comments
A great case from Military Hospital using Boston Scientific WATCHMAN FLX, demonstrating reliable performance in LAA management. The latest results of the Champion AF study showed:  WATCHMAN FLX provided statistically superior protection from bleeding and similar efficacy compared to NOACs in patients with NVAF. #WATCHMANFLX #structuralheart #AFib #cardiology #BostonScientific #DHSHungary #DeliveringHealthcareSolutions

Read More

A new milestone in structural heart innovation, Watchman FLX Pro

Boston Scientific, LAAC, Structural heart, WatchmanMarch 4, 2026291Views0Likes0Comments
The first Watchman FLX Pro implantation in Hungary has been successfully completed deploying the largest 40 mm device with outstanding performance. The implantation achieved an excellent position with optimal sealing, reinforcing the role of LAAC as a powerful alternative care strategy for patients with non-valvular atrial fibrillation who require a non-pharmacological approach to thromboembolic risk…

Read More

WATCHMAN™ FLX Implantation for a high bleeding risk patient at Military Hospital

Boston Scientific, Cardiology, WatchmanSeptember 9, 2025419Views0Likes0Comments
We are proud to spotlight an LAAC procedure where Prof. Dr. Gábor DURAY and Team have achieved what they commendably call a “perfect implantation” of the Boston Scientific WATCHMAN FLX™ device! The WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) procedure offers a one-time, minimally invasive alternative to lifelong anticoagulant therapy for patients with non-valvular atrial…

Read More

300th Watchman FLX case in Hungary

Boston Scientific, Milestone, Structural heart, WatchmanJune 25, 2025538Views0Likes0Comments
An important step in protecting patients from stroke risk due to atrial fibrillation: we proudly celebrated the 300th Watchman FLX procedure in Hungary with the EP Team of  Zala County Hospital. Boston Scientific Watchman FLX is designed for left atrial appendage closure (LAAC), offering an alternative to long-term anticoagulation in selected patients with non-valvular AF.…

Read More

Successful LAAC with Watchman FLX Device in High-Risk Patient

Boston Scientific, WatchmanMay 22, 2025503Views0Likes0Comments
86-year-old female patient with paroxysmal atrial fibrillation and atrial flutter, a CHAD-VASC score of 7, and a HAS-BLED score of 4, presented with a high bleeding risk and a history of stroke. Given these factors, Left Atrial Appendage Closure (LAAC) was performed using the BostonScientific Watchman FLX device as an alternative to long-term anticoagulation therapy.…

Read More

Advancing Stroke Prevention: The OPTION Trial

Boston Scientific, Innovation, LAAC, WatchmanJanuary 8, 2025529Views0Likes0Comments
Exciting news in the realm of stroke prevention! The OPTION Trial highlights the safety and effectiveness of left atrial appendage closure (LAAC) using the Watchman FLX™ device as an alternative to oral anticoagulants in patients undergoing AFib ablation. This study reinforces the potential of LAAC to reduce stroke risk while addressing bleeding concerns, offering hope…

Read More

Watchman FLX Device in Atrial Fibrillation Management

Boston Scientific, Cardiology, LAAC, WatchmanAugust 14, 2024432Views0Likes0Comments
The Left Atrial Appendage (LAA) closure is a crucial procedure to reduce the risk of thromboembolism in patients with non-valvular atrial fibrillation. Boston Scientific Watchman FLX device is particularly beneficial for patients who are at an increased risk for stroke and systemic embolism, as identified by CHA2DS2-VASc scores. It's especially valuable for those who are…

Read More

Routine Watchman™ FLX cases at Semmelweis University

Boston Scientific, LAAC, WatchmanMarch 17, 2023326Views0Likes0Comments
Watchman™ FLX implantation at Semmelweis University by Prof. Dr. László GELLÉR, Dr. Zoltán SALLÓ and Dr. Anikó NAGY. Watchman FLX has a robust clinical evidence background: The SURPASS analysis of the NCDR-LAAO Registry™ has data of 16.000+ patients to date and confirms the best-in-class safety profile of Watchman FLX. #dailywork #LAAC #Watchman #BostonScientific #medicaldevice…

Read More